Site Reference ID/Investigator #004 — Birmingham, Alabama

Site Reference ID/Investigator #004 is a clinical research site located in Birmingham, Alabama, United States 35249.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator #004 has participated in 1 clinical trials.

Therapeutic areas: Recurrent Ovarian Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma.

Sponsors: Corcept Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

• University of Alabama Birmingham - Main & Highlands
• University of Alabama Birmingham Lung Health Center
• University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic
• The University Of Alabama Of Birmingham
• University of Alabama at Birmingham, School of Optometry, Clinical Eye Research Facility
• University of Alabama at Birmingham - School of Medicine-Cardiology ( Site 0153)
• University of Alabama Hospitals
• UAB Hospital /ID# 262565
• University of Alabama at Birmingham Women & Infants Center
• University of Alabama at Birmingham (UAB) - Center for Education & Research on Therapeutics of Musculoskeletal Disorders
• University of Alabama at Birmingham Endocrinology Department
• University of Alabama-The Kirklin Clinic

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator #004?

Site Reference ID/Investigator #004 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator #004 conducted?

Site Reference ID/Investigator #004 has 1 clinical trials on record. Their work covers Recurrent Ovarian Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma.

Is Site Reference ID/Investigator #004 accredited by Crixeo Clinical Trials?

Site Reference ID/Investigator #004 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator #004?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.